Skip To Main Content
Non- Biological on Muck Rack

Non- Biological

As seen in: Benzinga, Fidelity Investments, MENAFN, PR Newswire UK, FinanzNachrichten.de, CEO, Canadian Insider, EMSF-Lisboa, ukbiotech.com
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Non-

Contact Non-, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Prophecy Market Insights: Orphan Drugs Market is estimated to be US$ 869.6 billion by 2030 with a CAGR of 10.4% during the forecast period

|
By Non- Biological, Drug type-, Disease Type-, Phase II
| FinanzNachrichten.de
COVINA, Calif., May 2, 2023 /PRNewswire/ -- According to prophecy market insights "Orphan Drugs Market is estimated to be US$ 869.6 million by 2030 with a CAGR of 10.4% during the forecast period" What is the Overview of Orphan Drugs Market? Orphan drugs are pharmaceutical products developed to treat rare diseases or conditions that affect a small number of people.
Open in Who Shared View Duplicates (55) Issue with article?
See all 12 articles